By Counterforce Health Team in Pemazyre (pemigatinib) —

Work With Your Doctor to Get Pemazyre (pemigatinib) Covered by UnitedHealthcare in Florida: Complete Provider Collaboration Guide

Answer Box: Getting Pemazyre Covered by UnitedHealthcare in Florida

UnitedHealthcare requires prior authorization for Pemazyre (pemigatinib) with FGFR2 fusion testing, prior therapy documentation, and ophthalmology monitoring plan. Work with your oncologist to submit: FDA-approved FGFR2 test results, gemcitabine/cisplatin failure records, baseline eye exam, and treatment plan via UHC Provider Portal. Standard decisions take 72 hours; expedited reviews 24 hours. If denied, file internal appeals within 180 days, then Florida external review within 4 months through Department of Financial Services.

First step today: Schedule appointment with your oncologist to review your FGFR2 test results and prior treatment history.

Table of Contents

  1. Set Your Goal: Understanding UnitedHealthcare's Requirements
  2. Visit Prep: Gathering Your Medical History
  3. Evidence Kit: Building Your Documentation Package
  4. Letter of Medical Necessity: What Your Doctor Needs to Write
  5. Peer-to-Peer Support: How to Help Your Provider
  6. After-Visit Summary: Staying Organized
  7. Respectful Persistence: Following Up Effectively
  8. Appeals Playbook for Florida
  9. Common Denial Reasons & Solutions
  10. FAQ

Set Your Goal: Understanding UnitedHealthcare's Requirements

Your partnership with your oncologist is crucial for Pemazyre approval. UnitedHealthcare's OptumRx division requires prior authorization effective January 1, 2025 for all cholangiocarcinoma patients.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It
FGFR2 fusion test FDA-approved assay (FoundationOne, Guardant360) Pathology report
Prior therapy Gemcitabine-based treatment tried/failed Treatment records
Ophthalmology plan Baseline exam + monitoring schedule Eye doctor consultation
Diagnosis confirmation Unresectable/metastatic cholangiocarcinoma Imaging reports
Authorization duration 12 months initially UHC PA policy

Your role: Come prepared with organized medical history and be your doctor's partner in building a complete case.

Visit Prep: Gathering Your Medical History

Before meeting with your oncologist, create a comprehensive timeline that will strengthen your prior authorization request.

Symptom and Treatment Timeline

Document these key points:

  • Initial symptoms: When did you first notice problems? Weight loss, abdominal pain, jaundice?
  • Diagnosis date: When was cholangiocarcinoma confirmed?
  • FGFR2 testing: When was molecular testing done? Do you have the report?
  • Previous treatments: List all therapies tried, including:
    • Gemcitabine + cisplatin (dates, cycles completed)
    • Any other chemotherapy regimens
    • Radiation therapy
    • Surgical procedures

Side Effects and Tolerability Notes

UnitedHealthcare often requires proof that standard treatments failed or weren't tolerated. Document:

  • Specific side effects from gemcitabine/cisplatin
  • Dose reductions or delays
  • Hospitalizations related to treatment
  • Reasons for stopping therapy (progression vs. toxicity)

Functional Impact Assessment

Note how your condition affects daily life:

  • Performance status changes
  • Work or activity limitations
  • Quality of life impact
Tip: Bring a written summary—your oncologist can reference specific dates and details when writing the medical necessity letter.

Evidence Kit: Building Your Documentation Package

Your oncologist needs specific documents to submit a strong prior authorization. Help gather:

Required Laboratory and Imaging

  • FGFR2 fusion test report from FDA-approved assay
  • Recent imaging (CT, MRI showing disease status)
  • Baseline labs (liver function, kidney function, blood counts)
  • Pathology report confirming cholangiocarcinoma diagnosis

Treatment History Documentation

  • Chemotherapy records with dates, doses, and outcomes
  • Progression documentation (imaging showing disease advancement)
  • Toxicity reports if treatments were stopped due to side effects

Ophthalmology Requirements

Schedule baseline comprehensive eye exam including:

  • Visual acuity testing
  • Optical coherence tomography (OCT)
  • Retinal examination for pigment epithelial changes

Pemazyre requires ongoing eye monitoring every 2 months for 6 months, then every 3 months.

Guidelines and References

Your doctor should reference:

  • FDA prescribing information for Pemazyre
  • NCCN Guidelines for cholangiocarcinoma
  • Published studies supporting FGFR2-targeted therapy

Letter of Medical Necessity: What Your Doctor Needs to Write

A strong medical necessity letter addresses UnitedHealthcare's specific criteria. Your oncologist should include:

Diagnosis Section

  • Confirmed cholangiocarcinoma (unresectable locally advanced or metastatic)
  • FGFR2 fusion/rearrangement via FDA-approved test
  • ICD-10 codes (C22.1 for intrahepatic, C24.0 for extrahepatic)

Clinical Rationale

  • Why Pemazyre is medically necessary for your specific case
  • How FGFR2 targeting addresses your tumor's biology
  • Expected clinical benefit based on trial data

Prior Treatment Documentation

  • Detailed gemcitabine-based therapy history
  • Specific reasons for failure (progression dates, imaging evidence)
  • Why alternative therapies are inappropriate

Safety Monitoring Plan

  • Ophthalmology monitoring schedule
  • Drug interaction assessment (CYP3A4 considerations)
  • Baseline organ function and monitoring plan

References

  • FDA approval for FGFR2-fusion cholangiocarcinoma
  • NCCN Category 1 recommendation
  • Published efficacy data (FIGHT-202 trial)

Peer-to-Peer Support: How to Help Your Provider

If your initial prior authorization is denied, your oncologist may request a peer-to-peer review with a UnitedHealthcare medical director.

How to Support Your Doctor

  • Provide availability windows: When can you be reached if questions arise?
  • Prepare a one-page summary: Key facts about your case in bullet points
  • Gather additional documentation: Recent labs, imaging, or treatment notes

Scheduling Peer-to-Peer Reviews

Your oncologist can:

  • Use UHC Provider Portal peer-to-peer request form
  • Call 1-877-844-4999 for appeals assistance
  • Request expedited review for urgent cases (1-800-711-4555)
Note: Peer-to-peer reviews often resolve clinical disagreements without formal appeals.

After-Visit Summary: Staying Organized

After your appointment, maintain organized records to support ongoing approval efforts.

What to Save

  • Prior authorization submission receipt (confirmation number)
  • Copies of all submitted documents
  • Provider portal login information (if given access)
  • Timeline of submission and expected decision date

Portal Communication

Many patients can track PA status through:

  • UnitedHealthcare member portal
  • Provider office patient portal
  • Specialty pharmacy coordination services

Documentation for Appeals

If denied, immediately save:

  • Denial letter with specific reasons
  • Policy language cited in denial
  • Additional clinical notes that address denial reasons

Respectful Persistence: Following Up Effectively

Approval processes take time, but appropriate follow-up ensures nothing falls through the cracks.

Follow-Up Cadence

  • 72 hours after submission: Confirm receipt with provider office
  • 1 week: Check status if no decision received
  • 2 weeks: Escalate to office manager if needed
  • At deadline: Prepare appeal if denied

How to Escalate Politely

When calling your provider's office:

  1. Be specific: "I'm following up on my Pemazyre prior auth submitted on [date]"
  2. Offer assistance: "Is there anything I can provide to help?"
  3. Ask for timeline: "When do you expect to hear back?"
  4. Request updates: "Can you call me with any news?"

When to Contact UnitedHealthcare Directly

You can call member services (number on your insurance card) to:

  • Confirm PA submission was received
  • Check processing status
  • Request expedited review if medically urgent

Appeals Playbook for Florida

If your prior authorization is denied, Florida law provides specific appeal rights.

Internal Appeals (Required First Step)

  • Timeline: 180 days from denial notice
  • Process: Submit via UHC Provider Portal or 1-877-844-4999
  • Decision timeframe: 30 days standard, 72 hours expedited
  • Required documents: Denial letter, additional clinical evidence, medical necessity letter

External Review (After Internal Appeals)

  • Timeline: 4 months from final internal denial
  • Process: File with Florida Department of Financial Services
  • Phone: 1-877-693-5236 (Insurance Consumer Helpline)
  • Cost: Free to consumers
  • Decision: Binding on UnitedHealthcare if approved

Expedited Appeals

For urgent medical situations:

  • Criteria: Treatment delay could seriously jeopardize health
  • Timeline: 72 hours for decision
  • Process: Call 1-800-711-4555 and request expedited review
Important: Florida's external review process has independent medical experts review your case. If they determine Pemazyre is medically necessary, UnitedHealthcare must cover it.

Common Denial Reasons & Solutions

Denial Reason How to Overturn Key Documentation
No FGFR2 fusion documented Submit FDA-approved test report FoundationOne, Guardant360 results
Insufficient prior therapy Provide detailed treatment history Gemcitabine/cisplatin records with progression
Missing ophthalmology plan Submit baseline eye exam Comprehensive ophthalmology consultation
Drug interactions Address CYP3A4 concerns Updated medication list with interaction assessment
Not medically necessary Strengthen clinical rationale NCCN guidelines, FDA approval, trial data
Step therapy not met Document contraindications/failures Specific reasons other treatments inappropriate

When facing insurance challenges with complex specialty medications like Pemazyre, many patients and providers turn to Counterforce Health for assistance. This platform specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with each payer's specific requirements.

FAQ

How long does UnitedHealthcare prior authorization take in Florida? Standard review takes up to 72 hours. Expedited reviews for urgent cases take up to 24 hours. Submit through the UHC Provider Portal for fastest processing.

What if Pemazyre is not on my formulary? UnitedHealthcare covers Pemazyre through OptumRx specialty pharmacy with prior authorization. Non-formulary status doesn't prevent coverage if medical necessity is established.

Can I request an expedited appeal? Yes, if treatment delay could seriously jeopardize your health. Call 1-800-711-4555 to request expedited review with 72-hour decision timeline.

Does step therapy apply if I failed treatments in another state? Yes, your complete treatment history counts regardless of where you received care. Provide documentation of all prior therapies tried and failed.

What happens if my doctor doesn't want to do a peer-to-peer review? You can request a second opinion or ask your doctor to refer you to an oncologist experienced with FGFR-targeted therapies and insurance appeals.

How much will Pemazyre cost with UnitedHealthcare coverage? Costs vary by plan. Specialty tier copays typically range from $100-500 monthly. Check with IncyteCARES for copay assistance programs.

Can I file an appeal myself without my doctor? While you have the right to appeal, medical appeals are most successful with physician support. Your doctor's clinical expertise and medical necessity documentation are crucial for approval.

What if I need Pemazyre for a different cancer type? UnitedHealthcare's current approval is specifically for FGFR2-fusion cholangiocarcinoma and FGFR1-rearranged myeloid/lymphoid neoplasms. Off-label use requires stronger medical necessity documentation and often faces higher denial rates.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider about your specific medical condition and treatment options. Insurance coverage decisions are made by your specific plan and may vary. For personalized assistance with insurance appeals and prior authorizations, consider consulting with Counterforce Health or other healthcare advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.